Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy

Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy

Targeting altered tumour metabolism is an emerging therapeutic strategy for cancer treatment. The metabolic reprogramming that accompanies the development of malignancy creates targetable differences between cancer cells and normal cells, which may be exploited for therapy. There is also emerging ev...

Bibliografske podrobnosti
Main Authors:	Jiaqi Li, Jie Qing Eu, Li Ren Kong, Lingzhi Wang, Yaw Chyn Lim, Boon Cher Goh, Andrea L. A. Wong
Format:	Article
Jezik:	English
Izdano:	MDPI AG 2020-10-01
Serija:	Molecules
Teme:	cancer cell metabolism tumour microenvironment metabolic reprogramming targeted therapy immunotherapy
Online dostop:	https://www.mdpi.com/1420-3049/25/20/4831

Podobne knjige/članki

Mitochondrial Retrograde Signalling and Metabolic Alterations in the Tumour Microenvironment
od: Dongki Yang, et al.
Izdano: (2019-03-01)

Metabolism, metabolites, and macrophages in cancer
od: Mengyuan Li, et al.
Izdano: (2023-07-01)

Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy
od: Yi Lin, et al.
Izdano: (2022-10-01)

Targeting T cell immunometabolism for cancer immunotherapy; understanding the impact of the tumour microenvironment
od: Mary B Mockler, et al.
Izdano: (2014-05-01)

Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment
od: Haixia Zhang, et al.
Izdano: (2024-09-01)

Autonomous glucose metabolic reprogramming of tumour cells under hypoxia: opportunities for targeted therapy
od: Mingyao Huang, et al.
Izdano: (2020-09-01)

Advances in macrophage and T cell metabolic reprogramming and immunotherapy in the tumor microenvironment
od: Hua Cheng, et al.
Izdano: (2024-01-01)

Glucose metabolism and tumour microenvironment in pancreatic cancer: A key link in cancer progression
od: Shi Dong, et al.
Izdano: (2022-12-01)

Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment
od: Yifei Zhu, et al.
Izdano: (2022-08-01)

Lighting Up the Fire in the Microenvironment of Cold Tumors: A Major Challenge to Improve Cancer Immunotherapy
od: Alice Benoit, et al.
Izdano: (2023-07-01)

Unlocking the potential of T‐cell metabolism reprogramming: Advancing single‐cell approaches for precision immunotherapy in tumour immunity
od: Lihaoyun Huang, et al.
Izdano: (2024-03-01)

Analyzing the impact of metabolism on immune cells in tumor microenvironment to promote the development of immunotherapy
od: Yanru Long, et al.
Izdano: (2024-01-01)

Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics
od: Soumik Pal, et al.
Izdano: (2022-12-01)

Identification of a novel lipid metabolism-related gene signature within the tumour immune microenvironment for breast cancer
od: Xu Chang, et al.
Izdano: (2022-05-01)

Mechanisms of HIF-driven immunosuppression in tumour microenvironment
od: Shinjini Bandopadhyay, et al.
Izdano: (2023-08-01)

The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy
od: Dongming Li, et al.
Izdano: (2024-01-01)

Metabolic reprogramming and immunological changes in the microenvironment of esophageal cancer: future directions and prospects
od: Zhi-Xun Guo, et al.
Izdano: (2025-01-01)

Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy
od: Ming Zhang, et al.
Izdano: (2022-09-01)

Glycolysis in the tumor microenvironment: a driver of cancer progression and a promising therapeutic target
od: Junpeng Zhao, et al.
Izdano: (2024-06-01)

Fine-Tuning the Tumour Microenvironment: Current Perspectives on the Mechanisms of Tumour Immunosuppression
od: Jesse D. Armitage, et al.
Izdano: (2021-01-01)

Effect of neoadjuvant chemotherapy on the immune microenvironment of gynaecological tumours
od: Jing Xue, et al.
Izdano: (2023-12-01)

Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy
od: Di Chen, et al.
Izdano: (2024-09-01)

A signature based on circadian rhythm-associated genes for the evaluation of prognosis and the tumour microenvironment in HNSCC
od: Changqian Wang, et al.
Izdano: (2024-03-01)

Editorial: Molecular biomarkers and imaging markers in the prediction, diagnosis, and prognosis of bladder cancer
od: Yongwen Luo, et al.
Izdano: (2022-10-01)

Advances in reprogramming of energy metabolism in tumor T cells
od: Liu Xuekai, et al.
Izdano: (2024-02-01)

Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy
od: Andrea Nicolini, et al.
Izdano: (2024-07-01)

Bicarbonate transport as regulator of antitumour immunity in pancreatic cancer
od: Emily J. Kay, et al.
Izdano: (2023-04-01)

Nanomedicines Targeting Metabolism in the Tumor Microenvironment
od: Mengdi Ren, et al.
Izdano: (2022-08-01)

Editorial: Tumor metabolic microenvironment: one man’s meat is another man’s poison
od: Jing Xu, et al.
Izdano: (2024-05-01)

Targeting tumour microenvironment by tyrosine kinase inhibitor
od: Hor-Yue Tan, et al.
Izdano: (2018-02-01)

m6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion
od: Xiaoxue Cao, et al.
Izdano: (2023-03-01)

Choline metabolism reprogramming mediates an immunosuppressive microenvironment in non-small cell lung cancer (NSCLC) by promoting tumor-associated macrophage functional polarization and endothelial cell proliferation
od: Bijing Xiao, et al.
Izdano: (2024-05-01)

High-ammonia microenvironment promotes stemness and metastatic potential in hepatocellular carcinoma through metabolic reprogramming
od: Renchao Zou, et al.
Izdano: (2025-02-01)

Editorial: Tumor microenvironment and metabolic reprogramming in cancer
od: Xiaoling Cui, et al.
Izdano: (2024-10-01)

Metabolic reprogramming in the tumor microenvironment of liver cancer
od: Jian Lin, et al.
Izdano: (2024-01-01)

LncRNAs in tumor metabolic reprogramming and tumor microenvironment remodeling
od: Jianhang Jiao, et al.
Izdano: (2024-10-01)

Macrophage metabolic reprogramming and atherosclerotic plaque microenvironment: Fostering each other?
od: Qi Xiao, et al.
Izdano: (2023-05-01)

A review of lactate-lactylation in malignancy: its potential in immunotherapy
od: Jinhui Zha, et al.
Izdano: (2024-05-01)

Molecular characteristics and immune microenvironment of gastrointestinal stromal tumours: targets for therapeutic strategies
od: Yang Yu, et al.
Izdano: (2024-07-01)

Remodeling the hepatic fibrotic microenvironment with emerging nanotherapeutics: a comprehensive review
od: Xingtao Zhao, et al.
Izdano: (2023-04-01)